Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma

Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma

Bibliographic Details
Main Authors:	Johnson C, Gorringe KL, Thompson ER, Opeskin K, Boyle SE, Wang Y, Hill P, Mann GB, Campbell IG
Format:	Article
Language:	English
Published:	BMC 2012-04-01
Series:	Hereditary Cancer in Clinical Practice
Online Access:	http://www.hccpjournal.com/content/10/S2/A93

Similar Items

DCIS (Ductal carcinoma in situ)-like invasive ductal carcinoma of the breast
by: Huanyu Zhao, et al.
Published: (2022-10-01)

Educational Case: Ductal Carcinoma In Situ (DCIS)
by: Miglena K. Komforti DO, et al.
Published: (2019-11-01)

Ductal carcinoma in situ (DCIS) in breast fibroadenoma
by: Manar El-Essawy, et al.
Published: (2020-05-01)

Ductal Carcinoma In Situ (DCIS) and Microinvasive DCIS: Role of Surgery in Early Diagnosis of Breast Cancer
by: Francesca Magnoni, et al.
Published: (2023-05-01)

Personalizing the Treatment of Women with Ductal Carcinoma In Situ (DCIS) Using the DCIS Score: A Qualitative Study on Score Use
by: Mary Ann O’Brien, et al.
Published: (2024-02-01)

Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)
by: Fredrik Wärnberg, et al.
Published: (2021-12-01)

Unusual mammography findings of patients with ductal carcinoma in situ (DCIS) of the breast.
by: F Ismail, et al.
Published: (2008-03-01)

Is there a difference in FDG PET findings of invasive ductal carcinoma of the breast with and without coexisting DCIS?
by: Ismet Sarikaya, et al.
Published: (2020-01-01)

The role of stromal immune microenvironment in the progression of ductal carcinoma in situ (DCIS) to invasive breast cancer
by: Anna Niwińska, et al.
Published: (2021-12-01)

Performance of linear and stochastic cell-growth model of Ductal Carcinoma In Situ (DCIS)
by: Nurul Anis, Abdul Satar, et al.
Published: (2025)

Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast
by: Sunil S. Badve, et al.
Published: (2022-08-01)

Molecular Signatures in Ductal Carcinoma In Situ (DCIS): A Systematic Review and Meta-Analysis
by: Drissa Ouattara, et al.
Published: (2023-03-01)

The natural history of ductal carcinoma in situ (DCIS) in simulation models: A systematic review
by: Keris Poelhekken, et al.
Published: (2023-10-01)

Effect of Quantitative Nuclear Image Features on Recurrence of Ductal Carcinoma In Situ (DCIS) of the Breast
by: Judith-Anne W. Chapman, et al.
Published: (2008-01-01)

Challenging paradigms: Long non-coding RNAs in breast ductal carcinoma in situ (DCIS)
by: Mary Ann Kosir, et al.
Published: (2013-04-01)

Assessment of Ki-67 proliferation index with deep learning in DCIS (ductal carcinoma in situ)
by: Lukasz Fulawka, et al.
Published: (2022-02-01)

Is palpable DCIS more aggressive than screen-detected DCIS?
by: Nina Balac, et al.
Published: (2023-01-01)

1501 Evidence of immune suppression in PBMC of patients newly diagnosed with ductal carcinoma in situ (DCIS)
by: Olivera J Finn, et al.
Published: (2023-11-01)

Ductal carcinoma in situ (DCIS) presenting as a cystic retroareolar lesion in an African American man
by: Amara Ndumele, et al.
Published: (2021-06-01)

Risk factors for Luminal A ductal carcinoma in situ (DCIS) and invasive breast cancer in the Carolina Breast Cancer Study.
by: Lindsay A Williams, et al.
Published: (2019-01-01)

Low CD10 mRNA expression identifies high-risk ductal carcinoma in situ (DCIS).
by: Jérôme Toussaint, et al.
Published: (2010-01-01)

Biological Markers Predictive of Invasive Recurrence in DCIS
by: Sharon Nofech-Mozes, et al.
Published: (2008-01-01)

Functional copy-number alterations in cancer.
by: Barry S Taylor, et al.
Published: (2008-09-01)

A longitudinal cohort study to identify risk factors for the development of invasive cancer in unresected DCIS
by: Maxwell, AJ, et al.
Published: (2018)

Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis.
by: Manasa Ramakrishna, et al.
Published: (2010-01-01)

Epigenetic Alterations in DCIS Progression: What Can lncRNAs Teach Us?
by: Igor Petrone, et al.
Published: (2023-05-01)

Relationship between altered myoepithelial phenotype and the inflammatory cell infiltrate in progression of DCIS
by: K. Ohaida, et al.
Published: (2021-04-01)

Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers
by: Renata Faermann, et al.
Published: (2022-01-01)

Penurunan Imunoekspresi P63 Pada Mioepitel Ductal Carcinoma In Situ (DCIS) Payudara Sebagai Prediktor Infiltrasi Tumor
by: Teresa Liliana Wargasetia, et al.
Published: (2009-03-01)

Glucose Uptake and Intracellular pH in a Mouse Model of Ductal Carcinoma In Situ (DCIS) Suggests Metabolic Heterogeneity
by: Rebecca C. Lobo, et al.
Published: (2016-08-01)

Correction: Identification of Candidate Growth Promoting Genes in Ovarian Cancer through Integrated Copy Number and Expression Analysis.
by: Manasa Ramakrishna, et al.
Published: (2011-01-01)

Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape
by: Tanjina Kader, et al.
Published: (2018-05-01)

A case of ductal carcinoma in situ (DCIS) with markedly elevated CA15-3 levels requiring 2 years of diagnosis
by: Mutsumi Fujimoto, et al.
Published: (2023-12-01)

Predicting Breast Cancer Events in Ductal Carcinoma In Situ (DCIS) Using Generative Adversarial Network Augmented Deep Learning Model
by: Soumya Ghose, et al.
Published: (2023-03-01)

Hypofractionation and Concomitant Boost in Ductal Carcinoma In Situ (DCIS): Analysis of a Prospective Case Series with Long-Term Follow-Up
by: Domenico Cante, et al.
Published: (2022-06-01)

S100A7 (Psoriasin), highly expressed in Ductal Carcinoma <it>In Situ </it>(DCIS), is regulated by IFN-gamma in mammary epithelial cells
by: Yhr Maria, et al.
Published: (2007-11-01)

Molecular and cellular characterization of two patient-derived ductal carcinoma in situ (DCIS) cell lines, ETCC-006 and ETCC-010
by: Julia Samson, et al.
Published: (2021-07-01)

Ductal carcinoma in situ (DCIS) and breast cancer-specific and all-cause mortality among postmenopausal women in the Women’s Health Initiative
by: K. Pan, et al.
Published: (2021-04-01)

Prognostic Value of Copy Number Alteration Burden in Early-Stage Breast Cancer and the Construction of an 11-Gene Copy Number Alteration Model
by: Dingyuan Wang, et al.
Published: (2022-08-01)

Integrated mutation, copy number and expression profiling in resectable non-small cell lung cancer
by: Do Hongdo, et al.
Published: (2011-03-01)